Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients
Drug-associated bullous pemphigoid has been shown to follow long-term gliptin (dipeptidyl-peptidase 4 inhibitors) intake. This study aimed at identifying risk factors for gliptin-associated bullous pemphigoid among patients with type 2 diabetes. A retrospective study was conducted in a tertiary cent...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Medical Journals Sweden
2024-04-01
|
| Ráidu: | Acta Dermato-Venereologica |
| Fáttát: | |
| Liŋkkat: | https://medicaljournalssweden.se/actadv/article/view/26663 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|